Contact lens profitability analysis FY2026 — Vision Source and Alcon pricing, annual supply both eyes
Contact Lens Profitability — FY2026
Vision Source private label vs branded — annual supply, both eyes
Category winner — annual profit per patient (both eyes)
Annual supply: monthly = 4 × 6-pk · biweekly = 8 × 6-pk · daily = 8 × 90-pk · weekly = 4 × 27-pk (both eyes). Profit = MSRP minus customer/partner price.
| Product | Category | Cost/box | MSRP/box | Margin | Patient/yr | Annual profit |
|---|
Green margin = above 55%. "winner" = highest annual profit in category. Annual supply: monthly 4×6-pk · biweekly 8×6-pk · daily 8×90-pk · weekly 4×27-pk.
The modality switch thesis
Every monthly or biweekly patient switched to daily generates 2–4× more annual practice profit. VS private label dailies capture maximum margin at the same patient MSRP as branded equivalents. All comparisons use private label on both sides.
Annual practice gain per patient — monthly/biweekly to daily switch (VS private label)
The private label advantage
AQUACLEAR, FRESH DAY, and REVEAL are CooperVision-manufactured lenses available exclusively through Vision Source — clinically equivalent to branded counterparts at lower practice cost. The patient pays the identical MSRP. Every dollar of cost savings is pure margin.
| Private label | Branded equivalent | Category | MSRP/box | PL profit/box | Brand profit/box | Extra/patient/yr |
|---|
Extra annual profit per patient — private label vs branded (sorted high to low)